Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.
Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.
Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.
The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.
Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.
Aramark’s shareholder Capital International Investors updated its ownership disclosure. The firm reports beneficial ownership of 10,282,079 Aramark common shares, equal to 3.9% of the 262,808,032 shares believed outstanding. It holds sole voting power over 10,259,260 shares and no shared voting or dispositive power.
The filing states the shares were acquired and are held in the ordinary course of business, not to change or influence control of Aramark.
Aramark director Karen Marie King reported routine equity-related transactions in company stock. On February 2, 2026, 32.211 shares of common stock were withheld at $38.49 per share to cover taxes tied to vesting of deferred stock units, leaving 37,619.128 shares beneficially owned.
On February 3, 2026, she received a grant of 5,124 deferred stock units at $38.06 per share. These units vest the day before the first annual stockholders' meeting after the grant date, subject to continued service, and will be settled in common shares upon vesting. After this grant, she beneficially owned 42,743.128 shares of Aramark common stock, held directly.
Aramark director Kenneth M. Keverian reported an equity award of 5,124 deferred stock units on February 3, 2026. The units are tied to Aramark common stock at a reference price of $38.06 per share.
After this grant, he beneficially owns 28,992.516 shares directly. According to the terms, the deferred stock units will vest on the day before the first annual stockholders' meeting after the grant date, assuming continued board service. If vested, they will be settled in shares of common stock on the first day of the seventh month after he leaves the board.
Aramark director Susan M. Cameron reported an equity award of 5,124 deferred stock units on common stock at $38.06 per share. After this grant on 02/03/2026, she beneficially owned 48,085.657 common shares in total, held directly.
The deferred stock units will vest on the day before the first annual stockholders' meeting of Aramark occurring after the grant date, provided she continues in service. Once vested, the units are scheduled to be settled in shares of Aramark common stock on the vesting date.
Aramark director Kevin Wills reported a new equity grant. On 02/03/2026, he received 5,124 deferred stock units at a reference price of $38.06 per share, increasing his beneficial ownership to 21,855.732 shares of common stock held directly.
The deferred stock units will vest on the day before the first annual stockholders' meeting of Aramark that occurs after the grant date, subject to his continued board service. If vested, they will be settled in shares of common stock on the first day of the seventh month after his departure from the board.
Aramark director Richard W. Dreiling received an award of 5,124 deferred stock units on common stock at $38.06 per unit. After this grant, he beneficially owns 13,821.184 shares directly. The units vest the day before the first annual stockholders’ meeting after the grant, subject to continued board service, and, if vested, will be settled in common shares on the first day of the seventh month after he leaves the board.
Aramark director Stephen I. Sadove received a grant of 7,751 deferred stock units of common stock on February 3, 2026 at $38.06 per unit. After this award, he beneficially owned 102,049.114 common shares directly and 15,000 common shares indirectly through a trust.
The deferred stock units will vest on the day before the first annual stockholders' meeting following the grant date, as long as Sadove continues his board service. If they vest, the units will be settled in Aramark common shares on the first day of the seventh month after he leaves the board.
Aramark director Brian M. DelGhiaccio received an equity award of 5,124 deferred stock units of common stock on February 3, 2026 at $38.06 per unit. After this grant, he beneficially owns 16,301.732 common shares or equivalents on a direct basis.
The deferred stock units will vest the day before the first annual stockholders' meeting after the grant date, subject to continued board service, and will be settled in common shares on the first day of the seventh month after his departure from the board.
Aramark director Greg Creed reported a grant of 5,124 deferred stock units of common stock at $38.06 per share. Following this award on 02/03/2026, he beneficially owned 66,373.661 shares directly and 12,475 shares indirectly through a trust.
The deferred stock units will vest on the day before the first annual stockholders' meeting held after the grant date, subject to his continued board service. If vested, they will be settled in common shares on the first day of the seventh month after he leaves the board.
Aramark director Bridgette P. Heller received an award of 5,124 deferred stock units of common stock at a reference price of $38.06 per share. After this grant, she beneficially owns 35,637.088 shares directly. These deferred stock units vest the day before the first annual stockholders’ meeting following the grant, as long as she continues serving on the board.
If the award vests, it will be settled in Aramark common stock on the first day of the seventh month after she leaves the board, turning the deferred units into actual shares at that time.